Nat. Drug & Alcohol Research Centre, Sydney, 2019. 1p.
Data from interviews conducted in Sydney and Canberra: estimated number of people who inject drugs in Aust. 15-64 years: 68,800 - 118,000, estimated 20% having viraemic infection.
Aust Society for HIV, Viral Hep & Sexual Health Medicine, Sydney, 2019. 31p.
Reports from clinicians, community, researchers and policymakers.
.
Nat Drug & Alcohol Research Centre, Sydney, 2019
Multiple resources with findings from interviews conducted annually from 2000-2019 with a cross-sectional sentinel group of people who regularly inject drugs recruited from all capital cities
Nat Drug & Alcohol Research Centre, Sydney, 2019
New info from respondents about experiences smoking crystal meth, and what they did when they could not source a commercial ball pipe (inc. injecting).
Infohep, London, 2019. 2p.
Simplified monitoring of hep C viral load tests at the beginning of treatment and 12 wks after results in cure rates equivalent to intensive monitoring during treatment (Aust study).
European Centre for Disease Prevention & Control, Stockholm, 2019. 8p.
"Latest evidence to help develop, implement, monitor and evaluate testing guidelines and programs.
Int Jn of Drug Policy (via Elsevier), London, 2019. 8p.
Details of HCV point-of-care tests, follow-up and linkage to treatment through NSPs acceptable to PWID.
London Joint Working Group on Substance Use & Hepatitis C, London, 2019. 1p.
Review of ‘phase 2’ of the pilot with positive results for pharmacy testing and treatment. Provides links to full reports.
Hepatitis Advisor, New York, 2019. 1p.
"Evidence that HCV reinfection rates are low among PWID; but data strongly indicate that reinfection is driven by ongoing IDU after treatment even among PWID on opioid agonist therapy.”
Nat Centre for Immunisation Research & Surveillance, Sydney, 2019. 13p.
Information on hepatitis B disease and the available vaccines to assist immunisation providers in the delivery of hepatitis B vaccinations.
The Lancet Gastroenterology and Hepatology, London, 2019. 2p abstract.
Findings showed that any intervention that can reduce HCV transmission among people who inject drugs will have a pronounced effect on country-level incidence of HCV.
Infectious Disease Advisor, New York 2019. 2p.
Among men who have sex with men (MSM) in Switzerland, both domestic and international transmission of hepatitis C virus infection have contributed significantly to the HCV epidemic.
Aust Society for HIV, Viral Hep & Sexual Health Medicine (ASHM), Sydney, 2018. 12p.
Apart from the situation of vit D deficiency, there are no convincing data that CMs alter the course of the illness significantly but patients may experience an improvement in symptoms and wellbeing.
Int Jn of Drug Policy (via Elsevier), New York, 2019. 8p.
Explores how IDU may affect treatment success and implications for decisions around whether/when to treat PWID.
Infectious Disease Advisor, New York, 2019. 3p.
People on opioid agonist therapy or with recent history of injecting: alcohol and drug use remained unchanged or decreased; needle sharing decreased gradually yet significantly during/ after treatment.
MedLine Plus, Bethesda, 2019. Searchable webpages
Tasty, healthy meals to help develop a healthy eating pattern: includes fat-free or low fat dairy, low saturated fats, trans fats, added sugars, and salt.
British Liver Trust, London, 2019. 19p.
Help patients keep track of important information related to the condition and includes a small ‘patient alert card’ for use with Healthcare Professionals.
HCV Action, UK, 2019. 4p.
Case study from homelessness charity Harbour Housing (Cornwall) who have a dedicated bed to support people with HCV experiencing homelessness.
Aust Society for HIV, Viral Hep & Sexual Health Medicine, Sydney, 2019. 45 min webinar
Provides the latest news and supports discussion with clients and community on testing, prevention, current treatments and management.
Aust Society for HIV, Viral Hep & Sexual Health Medicine, Sydney, 2019. 2p.
Chart showing treatment options for each genotype based on presence of cirrhosis and treatment experience; includes a quick reference treatment and post-treatment monitoring table.
Hepatitis NSW, Sydney 2019. 29p.
Comic-style stories about how to deal with discrimination in health services and how to disclose to new partners. Also contains treatment info, word games, sudoku and competitions.
Jn of Viral Hepatitis, John Wiley & Sons, Hoboken, 2019. 7p.
Antenatal HBV testing can inform prevalence estimates and vaccine program impact in countries with limited surveillance/high migration to Aust.
Poz, New York, 2018. 6p.
Ending the epidemic is going to require addressing the fact that certain individuals, including men who have sex with men, are at high risk of reinfection after a cure.
European Monitoring Centre for Drugs & Drug Addiction, Lisbon, 2019. 94p.
Presents a top-level overview, covering drug supply, use and public health problems as well as drug policy and responses.
For enquiries or feedback, please contact the librarian at Librarian@hepatitissa.asn.au.
| Address: | 3 Hackney Road Hackney SA 5069 |
| Phone: | (08) 8362 8443 |
| Fax: | (08) 8362 8559 |
| Email: | Librarian@hepatitissa.asn.au |
| Post: | PO Box 782 Kent Town SA 5071 |
Monday – Friday
9am to 5pm
Hepatitis SA is a non-profit, community-based organisation that provides information, education and support services to South Australians affected by hepatitis B and hepatitis C.